Latest Articles

Publication Date
All News Scientific
Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis - Proactive Investors Australia

Lisata Therapeutics strikes research partnership to investigate new treatment for endometriosis Proactive Investors Australia

Published: Oct. 28, 2024, 1:52 p.m.
Read Full Article
Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis - StockTitan

Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis StockTitan

Published: Oct. 28, 2024, 12:30 p.m.
Read Full Article
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - The Week

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation The Week

Published: Oct. 25, 2024, 5:28 a.m.
Read Full Article
HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward - Devdiscourse

HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward Devdiscourse

Published: Oct. 25, 2024, 5:14 a.m.
Read Full Article
Neoadjuvant Treatment Considerations for Endometrial Cancer - Cancer Network

Neoadjuvant Treatment Considerations for Endometrial Cancer Cancer Network

Published: Oct. 24, 2024, 6:19 p.m.
Read Full Article
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - BioSpace

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation BioSpace

Published: Oct. 24, 2024, 5:36 a.m.
Read Full Article
Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation - PR Newswire

Hope Medicine Inc. Announces Positive Results from a Global Phase 2 Study of a First-in-Class Endometriosis Treatment and Breakthrough Therapy Designation PR Newswire

Published: Oct. 24, 2024, 12:08 a.m.
Read Full Article
Prolonged Treatment for Endometriosis May Harm Live Birth Rate in IVF - Medpage Today

Prolonged Treatment for Endometriosis May Harm Live Birth Rate in IVF Medpage Today

Published: Oct. 23, 2024, 10:19 p.m.
Read Full Article
First Report of Sacituzumab Govitecan in Population Representing Current Treatment Experience - Medpage Today

First Report of Sacituzumab Govitecan in Population Representing Current Treatment Experience Medpage Today

Published: Oct. 23, 2024, 2:47 p.m.
Read Full Article
New hope for endometriosis: The revolutionary treatment scientists think might help sufferers - without medication - Daily Mail

New hope for endometriosis: The revolutionary treatment scientists think might help sufferers - without medication Daily Mail

Published: Oct. 21, 2024, 3:59 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!